Author
F. Hoffmann-La Roche AG
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
3 papers
Recent·Most cited
Manuel Tschan, Tania Jetzer, Melanie Obenloch…·Matthias P. Lütolf
This paper establishes a human lung explant model to quantify T cell bispecifics' on-target, off-tumor toxicity by measuring T cell activation and epithelial cell killing.
Martina Antoniolli, Llucia Albertí Servera, Kerstin Paetzold…·Steffen Dettling
The paper compares scRNA-seq protocols for clinical trial samples, finding that GEM-X Flex with chop-fix outperforms standard protocols and snRNA-seq in fixed tissue and FFPE blocks.
Carmen S. M. Yong, Irma Telarović, Lisa Gregor…·Onur Boyman
This study shows that timed CD25-biased IL-2 immunotherapy after RT enhances anti-tumor effects by promoting CD8+ T cell expansion and reducing exhaustion.